These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25414049)

  • 1. Patient preferences for change in symptoms associated with opioid-induced constipation.
    Epstein RS; Cimen A; Benenson H; Aubert RE; Khalid M; Sostek MB; Salimi T
    Adv Ther; 2014 Dec; 31(12):1263-71. PubMed ID: 25414049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid-Induced Constipation Survey in Patients with Chronic Noncancer Pain.
    Rauck RL; Hong KJ; North J
    Pain Pract; 2017 Mar; 17(3):329-335. PubMed ID: 26990277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When People with Opioid-Induced Constipation Speak: A Patient Survey.
    Epstein RS; Teagarden JR; Cimen A; Sostek M; Salimi T
    Adv Ther; 2017 Mar; 34(3):725-731. PubMed ID: 28181146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey.
    Emmanuel A; Johnson M; McSkimming P; Dickerson S
    Pain Med; 2017 Oct; 18(10):1932-1940. PubMed ID: 28339544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study.
    Keller MS; Jusufagic A; Spiegel BMR
    BMC Gastroenterol; 2019 Nov; 19(1):182. PubMed ID: 31718543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes.
    Coyne KS; Poon JL; Thompson C; Hu Y; Datto CJ; Sostek M
    Clin Ther; 2017 Jan; 39(1):75-88. PubMed ID: 27938897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.
    Koopmans-Klein G; Van Op den Bosch J; van Megen Y; Prenen H; Huygen F; Mancini I
    Curr Med Res Opin; 2017 Dec; 33(12):2217-2227. PubMed ID: 28805471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
    Gupta S; Patel H; Scopel J; Mody RR
    J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).
    Bell TJ; Panchal SJ; Miaskowski C; Bolge SC; Milanova T; Williamson R
    Pain Med; 2009 Jan; 10(1):35-42. PubMed ID: 18721170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
    Mehta V; Alaward S; Kuravinakop S; Nikolic S
    Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation.
    LoCasale RJ; Datto C; Margolis MK; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):246-53. PubMed ID: 27003554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
    Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
    Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.
    Spierings ELH; Drossman DA; Cryer B; Mazen Jamal M; Losch-Beridon T; Mareya SM; Wang M
    Pain Med; 2018 Jun; 19(6):1184-1194. PubMed ID: 29016868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
    Ueberall MA; Müller-Lissner S; Buschmann-Kramm C; Bosse B
    J Int Med Res; 2011; 39(1):41-50. PubMed ID: 21672306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.
    Marciniak CM; Toledo S; Lee J; Jesselson M; Bateman J; Grover B; Tierny J
    World J Gastroenterol; 2014 Nov; 20(43):16323-33. PubMed ID: 25473191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.